SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Anger Behind the Scenes When Valeant Jacked Up Price by 2,700% for Lead Poisoning Drug
Deals
Debt-Ridden Valeant Offloads Dendreon for $819.9 Million Cash
January 10, 2017
 · 
2 min read
Policy
Lawsuit: Valeant Is Letting “Female Viagra” Sales Sag
January 3, 2017
 · 
1 min read
Anger Behind the Scenes When Valeant Jacked Up Price by 2,700% for Lead Poisoning Drug
Investors, Put Your Emotions Aside: There is Hope for Valeant in 2017
December 29, 2016
 · 
2 min read
Anger Behind the Scenes When Valeant Jacked Up Price by 2,700% for Lead Poisoning Drug
Ackman Drops Some Valeant Shares, Papa Blames Media for Plummeting Share Prices
December 15, 2016
 · 
2 min read
Anger Behind the Scenes When Valeant Jacked Up Price by 2,700% for Lead Poisoning Drug
Business
Changing of the Guard at Valeant as 3 Execs Leave and New Dermatology Head Arrives
December 13, 2016
 · 
3 min read
Anger Behind the Scenes When Valeant Jacked Up Price by 2,700% for Lead Poisoning Drug
Business
Valeant’s $10 Billion Salix Deal With Takeda Falls Apart
December 1, 2016
 · 
2 min read
Policy
Why FDA Delay on Brodalumab is Actually Great News For Valeant
November 30, 2016
 · 
1 min read
Deals
Is This Valeant’s Next Pariah?
November 29, 2016
 · 
1 min read
Genetown
Valeant - The Asset Seller That Cried “Wolf”
November 21, 2016
 · 
1 min read
Load More
IN THE PRESS
Deals
Sanpower Group Completes The Acquisition Of Dendreon From Valeant
June 29, 2017
 · 
4 min read
Business
Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications
June 20, 2017
 · 
3 min read
Business
Valeant Surges As Its Largest Shareholder Joins Board
June 19, 2017
 · 
2 min read
Deals
Debt-Laden Valeant Unloads iNova Pharma In $930 Million Deal
June 8, 2017
 · 
3 min read
Business
EyeGate Pharma Receives Milestone Payment From Valeant For EGP-437 For Post-Operative Ocular Inflammation And Pain In Ocular Surgery Patients
May 22, 2017
 · 
3 min read
Policy
Valeant Release: Statement Regarding Xifaxan Intellectual Property Litigation
May 17, 2017
 · 
2 min read
Business
Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range
May 9, 2017
 · 
15 min read
Business
Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership
May 8, 2017
 · 
4 min read
Valeant Announces Additional Debt Reduction Of Approximately $220 Million
May 1, 2017
 · 
2 min read
Valeant’s Patient Access And Pricing Committee Announces Pricing For SILIQ (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis
April 21, 2017
 · 
4 min read
Load More